Microbiological tests comprise the studies of various types of microbial products such as bacteria, yeast, fungus, viruses and their effects on patient population. These products provide an array of experimental approaches (i.e. synthesis and sequencing) to either modify a biological system or mimic it. Microbiology testing technologies enables to examine presence of pathogenic micro-organisms or their metabolites by means of micro-biology techniques. Microbiological testing technologies have wide area of application in the field of healthcare (e.g. syphilis, tuberculosis, gastrointestinal tests), food industries (e.g. food safety testing) and environmental industries (e.g. environmental testing). The foremost objective to use microbiology testing technologies is to understand human diseases (e.g. cancers, genetic diseases and others) better than before and identify new molecular targets to facilitate drug discovery.
Rising incidences of infectious and sexually transmitted diseases globally will drive the market of microbiology testing. In addition, technological advancements have made microbiology tests faster and more accurate that increases the use of these tests and hence drives the growth of the market. Additionally, wide application areas of microbial test in the field of healthcare, energy and environment will further increase the uptake of nicrobiology technologies hence drives the market growth of microbiology testing technologies.
Moreover, introduction of new tests by key players will further drive the growth of microbiology testing technologies market globally. For example, in February 2012, BioControl Systems launched a new Non-O157 Shiga Toxigenic E.coli (STEC) test. This test is different in that it has advanced the techniques associated with food microbiology and molecular technology. More importantly, it aids in the quicker and more efficient detection of the non-O157 serotype of E.coli. Thus, such innovative launches by key players attract new customers to use microbiology tests and technologies and will consequently drive the growth of the market. However less specific actions of microbiology tests will restrain the growth of microbiological testing technologies market. In addition, insufficient regulatory framework and guidelines and high cost of microbial products will restrain the growth of microbiology testing technologies market.
Geographically, the most dominant region in the global microbiological testing technologies market is North America. The region’s leading position can be mainly ascribed to the presence of key players headquartered and/or operational in this region; many of these players offer an expansive portfolio of microbiological tests and technologies. Europe, which is the second-largest regional market for microbiology testing technologies, also holds promising opportunities.
Consistent advancements in the field of molecular diagnostic tests, such as the genetic probe test, for instance, coupled with positive initiatives by governments for the development of the field of microbiology will help stimulate advances in microbiology technologies. This will prove beneficial for the market’s growth in Europe. For example, in March 2012, Abbott Laboratories obtained the CE Mark approval in the European Union, which allowed it to market PLEX-ID. This instrument features advanced molecular diagnostic technology which makes it suited for detecting and identifying a broad range of microbes. With such new launches and approvals by government authorities, the uptake of microbiology testing technologies will eventually increase and lend support to the market’s growth.
In addition to traditional markets, countries in South-East Asia along with India and China are regarded as rapidly developing markets for microbiological testing technologies because of increasing acceptance of microbiology tests and technologies by biotechnology companies and others.
Request Free Sample of Research Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11603
Various key players actively participating in this market are Bio-Rad Laboratories, Inc., Abbott Laboratories, Gen-Prove, Inc., Agrivida, Inc., Agilent Technologies, Inc., Biosearch Technologies, Renewable Energy Group, Inc., ATG: biosynthetics GmbH, Torrey Pines Scientific, Inc., PSS Precision System Science, BioControl Systems and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.